financetom
Business
financetom
/
Business
/
Nissan seeks to learn from Chinese supplier strategies as part of cost-cutting drive
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nissan seeks to learn from Chinese supplier strategies as part of cost-cutting drive
Sep 16, 2025 10:05 PM

YOKOHAMA, Japan (Reuters) -Nissan Motor ( NSANF ) is studying the cost competitiveness of Chinese suppliers and exploring ways to apply their practices globally, as it aims to cut variable costs by 250 billion yen ($1.71 billion) in a broad efficiency drive, a senior executive said.

Tatsuzo Tomita, Nissan's ( NSANF ) chief of total delivered cost transformation, said the Japanese automaker was drawing lessons from its Chinese suppliers' use of standard parts and their close collaboration with designers.

"We've gained access to Chinese-style ways of working, and my current challenge is figuring out how to apply those methods to parts for our current and upcoming vehicles," Tomita told reporters at Nissan's ( NSANF ) head office in Yokohama on Wednesday.

As part of its ongoing turnaround plan that includes cutting about 20,000 jobs and consolidating seven plants, Nissan ( NSANF ) is targeting 500 billion yen of cost reductions by March 2027.

Half is expected to come from cuts to fixed costs and the remainder from slashing variable costs as it works to secure an operating profit and positive free cash flow in its automotive business by the financial year ending in March 2027.

Tomita said the company was not looking to shrink its supplier base, but to strengthen collaboration.

He noted Chinese suppliers were expanding globally, with operations in Hungary, Morocco and Turkey, and said Nissan ( NSANF ) was considering them as potential future partners in its international strategy.

While acknowledging the 250 billion yen variable cost reduction target was "massive," Tomita said it could be achievable if Nissan ( NSANF ) maintained its current momentum, which it had been building by sourcing thousands of ideas from employees.

The impact of the cost-saving measures was likely to materialise more widely by the end of the year or next year, as it differed from vehicle to vehicle, he added.

($1 = 146.5200 yen)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Moleculin Biotech Shares Rise After Announcing Preclinical Data for Annamycin Targeting Venetoclax-Resistant Leukemia
Moleculin Biotech Shares Rise After Announcing Preclinical Data for Annamycin Targeting Venetoclax-Resistant Leukemia
Dec 11, 2024
01:33 PM EST, 12/11/2024 (MT Newswires) -- Moleculin Biotech's ( MBRX ) shares were up nearly 9% in recent Wednesday trading after the company announced preclinical data showcasing its drug candidate Annamycin's efficacy against venetoclax-resistant acute myeloid leukemia, or AML, cell lines. Presented at the American Society of Hematology's Annual Meeting, the study showed that Annamycin effectively targets Cytarabine, or...
Sector Update: Consumer
Sector Update: Consumer
Dec 11, 2024
01:30 PM EST, 12/11/2024 (MT Newswires) -- Consumer stocks were mixed Wednesday afternoon with the Consumer Staples Select Sector SPDR Fund (XLP) fractionally lower and the Consumer Discretionary Select Sector SPDR Fund (XLY) rising 1.6%. In corporate news, Albertsons ( ACI ) terminated its planned $25 billion acquisition by Kroger ( KR ) after two courts ruled to block the...
What's Going On With Moleculin Biotech Shares Wednesday?
What's Going On With Moleculin Biotech Shares Wednesday?
Dec 11, 2024
Moleculin Biotech, Inc. ( MBRX ) shares are trading higher on Wednesday after the company announced the online publication of preclinical data for its Annamycin Venetoclax Resistant AML model. What To Know: The preclinical data suggests that Annamycin effectively targets acute myeloid leukemia (AML) cell lines resistant to Cytarabine (Ara-C) and Venetoclax (VEN) in lab tests using cells from patients...
Comcast Business to Acquire Connectivity Services Provider Nitel From Cinven
Comcast Business to Acquire Connectivity Services Provider Nitel From Cinven
Dec 11, 2024
01:33 PM EST, 12/11/2024 (MT Newswires) -- Comcast ( CMCSA ) subsidiary Comcast Business said Wednesday it has agreed to acquire Nitel, a Chicago-based connectivity services provider, from private equity firm Cinven. Financial details weren't disclosed. Nitel provides network-as-a-service and managed solutions to 6,600 US enterprise customers in financial services, healthcare, and education industries. Price: 39.70, Change: +0.17, Percent Change:...
Copyright 2023-2026 - www.financetom.com All Rights Reserved